{
  "nodes": [
    {
      "id": "node_001",
      "content": "Stage IVA, M1b and Stage IVB, M1c",
      "parent_ids": [],
      "children_ids": [
        "node_002"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_002",
      "content": "\u2022 Biomarker testing (NSCL-19)\nIf not previously done\n\u2022 Brain MRI with contrast\n\u2022 FDG-PET/CT scan\n\u2022 Pathologic confirmation of metastatic lesion, if possible",
      "parent_ids": [
        "node_001"
      ],
      "children_ids": [
        "node_003",
        "node_004"
      ],
      "tree_ids": [
        "NSCL-19"
      ],
      "footnote_labels": [
        "r",
        "k"
      ]
    },
    {
      "id": "node_003",
      "content": "PS 0\u20132",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_005",
        "node_006"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_004",
      "content": "PS 3\u20134",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_007"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_005",
      "content": "Solitary or limited metastases confirmed",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_008",
        "node_009"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "gg"
      ]
    },
    {
      "id": "node_006",
      "content": "Multiple lesions",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_010"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_007",
      "content": "Advanced/metastatic disease (NSCL-19)",
      "parent_ids": [
        "node_004"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-19"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_008",
      "content": "Brain",
      "parent_ids": [
        "node_005"
      ],
      "children_ids": [
        "node_011"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_009",
      "content": "Other site",
      "parent_ids": [
        "node_005"
      ],
      "children_ids": [
        "node_012"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_010",
      "content": "Advanced/metastatic disease (NSCL-19)",
      "parent_ids": [
        "node_006"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-19"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_011",
      "content": "Stereotactic radiosurgery (SRS) alone\nor\nSurgical resection, if symptomatic or warranted for diagnosis, followed by SRS or whole brain RT (WBRT)",
      "parent_ids": [
        "node_008"
      ],
      "children_ids": [
        "node_013"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_012",
      "content": "Treatment of Thoracic Disease (NSCL-16)",
      "parent_ids": [
        "node_009"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-16"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_013",
      "content": "Treatment of Thoracic Disease (NSCL-16)",
      "parent_ids": [
        "node_011"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-16"
      ],
      "footnote_labels": []
    }
  ],
  "tree_references": [
    {
      "from_tree": "NSCL-15",
      "to_tree": "NSCL-19",
      "description": "Biomarker testing guidelines"
    },
    {
      "from_tree": "NSCL-15",
      "to_tree": "NSCL-19",
      "description": "Management of advanced/metastatic disease"
    },
    {
      "from_tree": "NSCL-15",
      "to_tree": "NSCL-16",
      "description": "Treatment of Thoracic Disease"
    }
  ],
  "footnotes": [
    {
      "label": "k",
      "content": "FDG-PET/CT performed skull base to mid-thigh. Positive FDG-PET/CT scan findings for distant disease need pathologic or other radiologic confirmation. If FDG-PET/CT scan is positive in the mediastinum, lymph node status needs pathologic confirmation."
    },
    {
      "label": "r",
      "content": "If MRI is not possible, CT of head with contrast."
    },
    {
      "label": "gg",
      "content": "Including selected patients with stage M1c and limited number and volume of metastatic lesions amenable to definitive local therapy. Clinical trials have included up to 3 to 5 metastatic sites."
    },
    {
      "label": "hh",
      "content": "NCCN Guidelines for Central Nervous System Cancers."
    }
  ],
  "extraction_confidence": 0.98,
  "image_title": "NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer",
  "tree_id": "NSCL-15"
}